(2R,3R)-N-[(1S,7R,8R,17S,20R,21S,24R,29S,32R)-29-benzyl-24-[(2S)-butan-2-yl]-8-(butylsulfanylmethyl)-8-hydroxy-32-[(1R)-1-hydroxyethyl]-7,20,28-trimethyl-11,14,18,22,25,27,30,33-octaoxo-6,15,19-trioxa-12,23,26,28,31,34-hexazatricyclo[15.9.8.22,5]hexatriaconta-2(36),3,5(35),9-tetraen-21-yl]-3-hydroxy-2,4-dimethylpentanamide

C55H79N7O15S — CID 123968725

IUPAC(2R,3R)-N-[(1S,7R,8R,17S,20R,21S,24R,29S,32R)-29-benzyl-24-[(2S)-butan-2-yl]-8-(butylsulfanylmethyl)-8-hydroxy-32-[(1R)-1-hydroxyethyl]-7,20,28-trimethyl-11,14,18,22,25,27,30,33-octaoxo-6,15,19-trioxa-12,23,26,28,31,34-hexazatricyclo[15.9.8.22,5]hexatriaconta-2(36),3,5(35),9-tetraen-21-yl]-3-hydroxy-2,4-dimethylpentanamide
SMILESCCCCSC[C@@]1(O)C=CC(=O)NCC(=O)OC[C@@H]2NC(=O)[C@@H]([C@@H](C)O)NC(=O)[C@H](Cc3ccccc3)N(C)C(=O)[C@@H](NC(=O)[C@@H]([C@@H](C)CC)NC(=O)[C@@H](NC(=O)[C@H](C)[C@H](O)C(C)C)[C@@H](C)OC2=O)c2ccc(cc2)O[C@@H]1C
InChIInChI=1S/C55H79N7O15S/c1-11-13-25-78-29-55(74)24-23-41(64)56-27-42(65)75-28-39-54(73)76-34(8)45(60-48(67)32(6)47(66)30(3)4)52(71)58-43(31(5)12-2)50(69)61-46(37-19-21-38(22-20-37)77-35(55)9)53(72)62(10)40(26-36-17-15-14-16-18-36)49(68)59-44(33(7)63)51(70)57-39/h14-24,30-35,39-40,43-47,63,66,74H,11-13,25-29H2,1-10H3,(H,56,64)(H,57,70)(H,58,71)(H,59,68)(H,60,67)(H,61,69)/t31-,32+,33+,34+,35+,39-,40-,43+,44+,45-,46-,47+,55-/m0/s1
InChIKeyBHJNTNLGKHXSBI-DNWAEDRGSA-N
MW1110.34 g/mol
LogP1.14
Rot. Bonds14

About (2R,3R)-N-[(1S,7R,8R,17S,20R,21S,24R,29S,32R)-29-benzyl-24-[(2S)-butan-2-yl]-8-(butylsulfanylmethyl)-8-hydroxy-32-[(1R)-1-hydroxyethyl]-7,20,28-trimethyl-11,14,18,22,25,27,30,33-octaoxo-6,15,19-trioxa-12,23,26,28,31,34-hexazatricyclo[15.9.8.22,5]hexatriaconta-2(36),3,5(35),9-tetraen-21-yl]-3-hydroxy-2,4-dimethylpentanamide

(2R,3R)-N-[(1S,7R,8R,17S,20R,21S,24R,29S,32R)-29-benzyl-24-[(2S)-butan-2-yl]-8-(butylsulfanylmethyl)-8-hydroxy-32-[(1R)-1-hydroxyethyl]-7,20,28-trimethyl-11,14,18,22,25,27,30,33-octaoxo-6,15,19-trioxa-12,23,26,28,31,34-hexazatricyclo[15.9.8.22,5]hexatriaconta-2(36),3,5(35),9-tetraen-21-yl]-3-hydroxy-2,4-dimethylpentanamide (PubChem CID 123968725) has the molecular formula C55H79N7O15S and a molecular weight of 1110.34 g/mol. Its IUPAC name is (2R,3R)-N-[(1S,7R,8R,17S,20R,21S,24R,29S,32R)-29-benzyl-24-[(2S)-butan-2-yl]-8-(butylsulfanylmethyl)-8-hydroxy-32-[(1R)-1-hydroxyethyl]-7,20,28-trimethyl-11,14,18,22,25,27,30,33-octaoxo-6,15,19-trioxa-12,23,26,28,31,34-hexazatricyclo[15.9.8.22,5]hexatriaconta-2(36),3,5(35),9-tetraen-21-yl]-3-hydroxy-2,4-dimethylpentanamide.

Molecular Properties

Compound Name(2R,3R)-N-[(1S,7R,8R,17S,20R,21S,24R,29S,32R)-29-benzyl-24-[(2S)-butan-2-yl]-8-(butylsulfanylmethyl)-8-hydroxy-32-[(1R)-1-hydroxyethyl]-7,20,28-trimethyl-11,14,18,22,25,27,30,33-octaoxo-6,15,19-trioxa-12,23,26,28,31,34-hexazatricyclo[15.9.8.22,5]hexatriaconta-2(36),3,5(35),9-tetraen-21-yl]-3-hydroxy-2,4-dimethylpentanamide
PubChem CID123968725
Molecular FormulaC55H79N7O15S
Molecular Weight1110.34 g/mol
Exact Mass1109.54
IUPAC Name(2R,3R)-N-[(1S,7R,8R,17S,20R,21S,24R,29S,32R)-29-benzyl-24-[(2S)-butan-2-yl]-8-(butylsulfanylmethyl)-8-hydroxy-32-[(1R)-1-hydroxyethyl]-7,20,28-trimethyl-11,14,18,22,25,27,30,33-octaoxo-6,15,19-trioxa-12,23,26,28,31,34-hexazatricyclo[15.9.8.22,5]hexatriaconta-2(36),3,5(35),9-tetraen-21-yl]-3-hydroxy-2,4-dimethylpentanamide
SMILESCCCCSC[C@@]1(O)C=CC(=O)NCC(=O)OC[C@@H]2NC(=O)[C@@H]([C@@H](C)O)NC(=O)[C@H](Cc3ccccc3)N(C)C(=O)[C@@H](NC(=O)[C@@H]([C@@H](C)CC)NC(=O)[C@@H](NC(=O)[C@H](C)[C@H](O)C(C)C)[C@@H](C)OC2=O)c2ccc(cc2)O[C@@H]1C
InChIInChI=1S/C55H79N7O15S/c1-11-13-25-78-29-55(74)24-23-41(64)56-27-42(65)75-28-39-54(73)76-34(8)45(60-48(67)32(6)47(66)30(3)4)52(71)58-43(31(5)12-2)50(69)61-46(37-19-21-38(22-20-37)77-35(55)9)53(72)62(10)40(26-36-17-15-14-16-18-36)49(68)59-44(33(7)63)51(70)57-39/h14-24,30-35,39-40,43-47,63,66,74H,11-13,25-29H2,1-10H3,(H,56,64)(H,57,70)(H,58,71)(H,59,68)(H,60,67)(H,61,69)/t31-,32+,33+,34+,35+,39-,40-,43+,44+,45-,46-,47+,55-/m0/s1
InChIKeyBHJNTNLGKHXSBI-DNWAEDRGSA-N
XLogP1.14
TPSA317.43 Ų
H-Bond Donors9
H-Bond Acceptors16
Rotatable Bonds14
Heavy Atoms78
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001110.34
LogP ≤ 51.14
H-Bond Donors ≤ 59
H-Bond Acceptors ≤ 1016

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze (2R,3R)-N-[(1S,7R,8R,17S,20R,21S,24R,29S,32R)-29-benzyl-24-[(2S)-butan-2-yl]-8-(butylsulfanylmethyl)-8-hydroxy-32-[(1R)-1-hydroxyethyl]-7,20,28-trimethyl-11,14,18,22,25,27,30,33-octaoxo-6,15,19-trioxa-12,23,26,28,31,34-hexazatricyclo[15.9.8.22,5]hexatriaconta-2(36),3,5(35),9-tetraen-21-yl]-3-hydroxy-2,4-dimethylpentanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (2R,3R)-N-[(1S,7R,8R,17S,20R,21S,24R,29S,32R)-29-benzyl-24-[(2S)-butan-2-yl]-8-(butylsulfanylmethyl)-8-hydroxy-32-[(1R)-1-hydroxyethyl]-7,20,28-trimethyl-11,14,18,22,25,27,30,33-octaoxo-6,15,19-trioxa-12,23,26,28,31,34-hexazatricyclo[15.9.8.22,5]hexatriaconta-2(36),3,5(35),9-tetraen-21-yl]-3-hydroxy-2,4-dimethylpentanamide?
The IUPAC name of (2R,3R)-N-[(1S,7R,8R,17S,20R,21S,24R,29S,32R)-29-benzyl-24-[(2S)-butan-2-yl]-8-(butylsulfanylmethyl)-8-hydroxy-32-[(1R)-1-hydroxyethyl]-7,20,28-trimethyl-11,14,18,22,25,27,30,33-octaoxo-6,15,19-trioxa-12,23,26,28,31,34-hexazatricyclo[15.9.8.22,5]hexatriaconta-2(36),3,5(35),9-tetraen-21-yl]-3-hydroxy-2,4-dimethylpentanamide (CID 123968725) is (2R,3R)-N-[(1S,7R,8R,17S,20R,21S,24R,29S,32R)-29-benzyl-24-[(2S)-butan-2-yl]-8-(butylsulfanylmethyl)-8-hydroxy-32-[(1R)-1-hydroxyethyl]-7,20,28-trimethyl-11,14,18,22,25,27,30,33-octaoxo-6,15,19-trioxa-12,23,26,28,31,34-hexazatricyclo[15.9.8.22,5]hexatriaconta-2(36),3,5(35),9-tetraen-21-yl]-3-hydroxy-2,4-dimethylpentanamide.
What is the SMILES notation for (2R,3R)-N-[(1S,7R,8R,17S,20R,21S,24R,29S,32R)-29-benzyl-24-[(2S)-butan-2-yl]-8-(butylsulfanylmethyl)-8-hydroxy-32-[(1R)-1-hydroxyethyl]-7,20,28-trimethyl-11,14,18,22,25,27,30,33-octaoxo-6,15,19-trioxa-12,23,26,28,31,34-hexazatricyclo[15.9.8.22,5]hexatriaconta-2(36),3,5(35),9-tetraen-21-yl]-3-hydroxy-2,4-dimethylpentanamide?
The canonical SMILES for (2R,3R)-N-[(1S,7R,8R,17S,20R,21S,24R,29S,32R)-29-benzyl-24-[(2S)-butan-2-yl]-8-(butylsulfanylmethyl)-8-hydroxy-32-[(1R)-1-hydroxyethyl]-7,20,28-trimethyl-11,14,18,22,25,27,30,33-octaoxo-6,15,19-trioxa-12,23,26,28,31,34-hexazatricyclo[15.9.8.22,5]hexatriaconta-2(36),3,5(35),9-tetraen-21-yl]-3-hydroxy-2,4-dimethylpentanamide is CCCCSC[C@@]1(O)C=CC(=O)NCC(=O)OC[C@@H]2NC(=O)[C@@H]([C@@H](C)O)NC(=O)[C@H](Cc3ccccc3)N(C)C(=O)[C@@H](NC(=O)[C@@H]([C@@H](C)CC)NC(=O)[C@@H](NC(=O)[C@H](C)[C@H](O)C(C)C)[C@@H](C)OC2=O)c2ccc(cc2)O[C@@H]1C.
What is the InChIKey of (2R,3R)-N-[(1S,7R,8R,17S,20R,21S,24R,29S,32R)-29-benzyl-24-[(2S)-butan-2-yl]-8-(butylsulfanylmethyl)-8-hydroxy-32-[(1R)-1-hydroxyethyl]-7,20,28-trimethyl-11,14,18,22,25,27,30,33-octaoxo-6,15,19-trioxa-12,23,26,28,31,34-hexazatricyclo[15.9.8.22,5]hexatriaconta-2(36),3,5(35),9-tetraen-21-yl]-3-hydroxy-2,4-dimethylpentanamide?
The InChIKey is BHJNTNLGKHXSBI-DNWAEDRGSA-N. The full InChI is InChI=1S/C55H79N7O15S/c1-11-13-25-78-29-55(74)24-23-41(64)56-27-42(65)75-28-39-54(73)76-34(8)45(60-48(67)32(6)47(66)30(3)4)52(71)58-43(31(5)12-2)50(69)61-46(37-19-21-38(22-20-37)77-35(55)9)53(72)62(10)40(26-36-17-15-14-16-18-36)49(68)59-44(33(7)63)51(70)57-39/h14-24,30-35,39-40,43-47,63,66,74H,11-13,25-29H2,1-10H3,(H,56,64)(H,57,70)(H,58,71)(H,59,68)(H,60,67)(H,61,69)/t31-,32+,33+,34+,35+,39-,40-,43+,44+,45-,46-,47+,55-/m0/s1.
What are the key properties of (2R,3R)-N-[(1S,7R,8R,17S,20R,21S,24R,29S,32R)-29-benzyl-24-[(2S)-butan-2-yl]-8-(butylsulfanylmethyl)-8-hydroxy-32-[(1R)-1-hydroxyethyl]-7,20,28-trimethyl-11,14,18,22,25,27,30,33-octaoxo-6,15,19-trioxa-12,23,26,28,31,34-hexazatricyclo[15.9.8.22,5]hexatriaconta-2(36),3,5(35),9-tetraen-21-yl]-3-hydroxy-2,4-dimethylpentanamide?
(2R,3R)-N-[(1S,7R,8R,17S,20R,21S,24R,29S,32R)-29-benzyl-24-[(2S)-butan-2-yl]-8-(butylsulfanylmethyl)-8-hydroxy-32-[(1R)-1-hydroxyethyl]-7,20,28-trimethyl-11,14,18,22,25,27,30,33-octaoxo-6,15,19-trioxa-12,23,26,28,31,34-hexazatricyclo[15.9.8.22,5]hexatriaconta-2(36),3,5(35),9-tetraen-21-yl]-3-hydroxy-2,4-dimethylpentanamide has a molecular weight of 1110.34 g/mol, XLogP of 1.14, 14 rotatable bonds, 9 hydrogen bond donors, and 16 hydrogen bond acceptors.
Where does this data come from?
All data for (2R,3R)-N-[(1S,7R,8R,17S,20R,21S,24R,29S,32R)-29-benzyl-24-[(2S)-butan-2-yl]-8-(butylsulfanylmethyl)-8-hydroxy-32-[(1R)-1-hydroxyethyl]-7,20,28-trimethyl-11,14,18,22,25,27,30,33-octaoxo-6,15,19-trioxa-12,23,26,28,31,34-hexazatricyclo[15.9.8.22,5]hexatriaconta-2(36),3,5(35),9-tetraen-21-yl]-3-hydroxy-2,4-dimethylpentanamide is sourced from PubChem (CID 123968725), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).